Award recordCONTRACT

CSL BEHRING L.L.C.

PIID VA26313J1539· VHA· 618-MINNEAPOLIS VA MEDICAL CENTER· 6505 · DRUGS AND BIOLOGICALS· FY2013· $4,283 net obligations· UEI H3WKVE9VBLY3· PA

Description

IGF::CT::IGF HIZENTRA MEDICATION ORDER

First action · last action
2013-06-14 · 2013-08-29
Transactions
2
First transaction's obligation
$4,199
Base + all options value (sum of deltas)
$4,283
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5045B
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$4,283$0Base award · 2013-06-14 · this action $4,199 · running total $4,199Modification P00001 · 2013-08-29 · this action $84 · running total $4,283
  • Base2013-06-14+$4,199= $4,199
  • Mod P000012013-08-29+$84= $4,283
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2013-06-14+$4,199$4,199IGF::CT::IGF HIZENTRA MEDICATION ORDER
Mod P00001· CHANGE ORDER2013-08-29+$84$4,283IGF::CT::IGF HIZENTRA MEDICATION ORDER

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI H3WKVE9VBLY3)

AwardOffice · PSC / listingNet obligationsFY
36C24826F0207248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$183,903FY2026
36C24826F0187248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$36,781FY2026
36C25226F0318252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$85,484FY2026
36C24826F0091248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$147,122FY2026
36C24826F0037248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$124,240FY2026
36C24824F0327248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$391,583FY2024

Other recipients under 6505 from 618-MINNEAPOLIS VA MEDICAL CENTER (most recent first)

AwardRecipientOfficeNet obligationsFY
VA26316E0587MCKESSON CORPORATION618-MINNEAPOLIS VA MEDICAL CENTER$11,602,626FY2016
VA26316E0586MCKESSON CORPORATION618-MINNEAPOLIS VA MEDICAL CENTER$7,713,803FY2016
VA26316E0442MCKESSON CORPORATION618-MINNEAPOLIS VA MEDICAL CENTER$7,309,602FY2016
VA26316E0132MCKESSON CORPORATION618-MINNEAPOLIS VA MEDICAL CENTER$7,862,529FY2016
VA26316E0111MCKESSON CORPORATION618-MINNEAPOLIS VA MEDICAL CENTER$5,614,469FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26313J1539_3600_V797P5045B_3600 · retrieved 2026-09-26.